Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China flag China · Delayed Price · Currency is CNY
8.70
+0.40 (4.82%)
Aug 20, 2026, 3:04 PM CST

SHE:300016 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
429.29295.44257.46748.45766.73895.02
Trading Asset Securities
371.13379.75350.77---
Cash & Short-Term Investments
800.42675.18608.23748.45766.73895.02
Cash Growth
-4.07%11.01%-18.73%-2.38%-14.33%-11.71%
Accounts Receivable
238.25265.25176.36188.55112.67142.52
Other Receivables
0.848.079.545.878.395.81
Receivables
239.09273.32185.9194.42121.06148.33
Inventory
355.93383.75362.09244.86276.22250.01
Other Current Assets
51.5744.5614.959.071412.72
Total Current Assets
1,4471,3771,1711,1971,1781,306
Property, Plant & Equipment
1,1401,125976.03876.23840.46795.3
Long-Term Investments
184.46578.74536.76556.06561.19553.2
Goodwill
46.9246.9246.92-31.8251.23
Other Intangible Assets
143.72147.22160.82128.39125.1138.99
Long-Term Accounts Receivable
1.321.311.43---
Long-Term Deferred Tax Assets
35.623741.3341.3839.3218.15
Long-Term Deferred Charges
25.1225.2724.9417.236.9532.4
Other Long-Term Assets
415.369.3118.113.385.838.92
Total Assets
3,4393,3482,9782,8192,8192,904

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
196.31214.38171.32115.12140.9141.13
Accrued Expenses
14.6555.0844.534.8932.0526.06
Short-Term Debt
283.6216.96140.02175.56107.6179.08
Current Portion of Long-Term Debt
23.4537.554912.410.0920.13
Current Portion of Leases
-0.923.263.042.740.27
Current Income Taxes Payable
18.767.84---0.01
Current Unearned Revenue
6.326.668.762.014.453.8
Other Current Liabilities
61.8235.0138.3816.144.8315.09
Total Current Liabilities
604.9574.39455.23359.17302.67285.56
Long-Term Debt
265.89248.79600.24592.55516.28476.1
Long-Term Leases
1.752.164.87.179.980.14
Long-Term Unearned Revenue
22.324.5216.8411.747.8910.45
Long-Term Deferred Tax Liabilities
80.1480.570.9362.4858.5645.98
Total Liabilities
974.97930.361,1481,033895.39818.22

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
562.87562.87491.95491.93491.96492.72
Additional Paid-In Capital
697.91697.91135.34135.22135.3201.27
Retained Earnings
1,040994.58926.45912.791,0191,042
Treasury Stock
-----0.1-9.06
Comprehensive Income & Other
4.023.36113.86110.67130.27130.04
Total Common Equity
2,3042,2591,6681,6511,7761,857
Minority Interest
159.93158.45161.9135.69146.88229.03
Shareholders' Equity
2,4642,4171,8291,7861,9232,086
Total Liabilities & Equity
3,4393,3482,9782,8192,8192,904

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
574.69506.37797.32790.72646.71575.72
Net Cash (Debt)
225.73168.81-189.09-42.28120.03319.31
Net Cash Growth
-----62.41%2.79%
Net Cash Per Share
0.420.33-0.42-0.090.210.66
Filing Date Shares Outstanding
562.87562.87491.95491.93491.96492.72
Total Common Shares Outstanding
562.87562.87491.95491.93491.96492.72
Working Capital
842.1802.42715.95837.62875.341,021
Book Value Per Share
4.094.013.393.363.613.77
Tangible Book Value
2,1142,0651,4601,5221,6191,667
Tangible Book Value Per Share
3.763.672.973.093.293.38
Buildings
-699.61700.49561.7557.21532.04
Machinery
-609.14567.37503.01470.31400.02
Construction In Progress
-260.8770.26110.3944.9949